RSS

oncology

Russian biotechnology company, BIOCAD, has revealed plans to enter the European market with oncological and autoimmune medicines. more

31 Oct 2017 10:45 News

A retrospective cohort study has found no conclusive evidence that most oncology treatments approved for use by the EMA offered survival or quality of life benefits to patients, giving rise to calls for an increase in the evidence bar. more

6 Oct 2017 12:34 News

An integrated oncology platform from Crown Bioscience has helped to advance the preclinical development of a HERA-GITRL immunotherapy from Apogenix for non-small cell lung cancer (NSCLC) and head and neck cancer. more

14 Sep 2017 12:13 Technology

Following disappointing announcements this week concerning the unmet primary endpoints of their Phase III trials, Merck and AstraZeneca have today revealed they are entering a strategic oncology collaboration. more

27 Jul 2017 11:50 News

The Lead Discovery Center (LDC), Max Planck Innovation and SOTIO have signed a collaboration and licence agreement providing SOTIO with exclusive rights to an oncology programme addressing a novel target in tumour metabolism. more

12 Apr 2017 10:54 News

Scientists and staff from academic research institutes and the pharma industry will be able to be informed on the latest trends and challenges within the field of oncology at the Sartorius Research Xchange Forum 2017. more

29 Nov 2016 16:40 News

Novartis has announced a strategic alliance and licensing agreement with Surface Oncology to grow its immune-oncology pipeline more

11 Jan 2016 11:52 News

Sanofi is extending its existing collaboration with Warp Drive Bio to discover novel oncology therapeutics and antibiotics more

11 Jan 2016 10:13 News

Array BioPharma and Pierre Fabre have announced a collaboration to globally develop and commercialise Array's late-stage novel oncology products, binimetinib and encorafenib more

3 Dec 2015 10:46 News

Catalent has signed an exclusive licencing agreement to access Excelimmune's antibody combination therapy technology platform, which has the potential to pave the way for more consistent, cost-effective production of antibody combinations. more

7 Jul 2015 15:59 News

Regulatory affairs services provider ELC Group is expanding into the pharmaceutical development market with the creation of an extensive product portfolio targeting a range of therapeutic areas. more

11 Jun 2015 12:00 News

The Institut Curie oncology research centre in Paris, France, has standardised on using MEDIACLAVE media preparation and MEDIAJET automated petri dish filling systems from INTEGRA Biosciences to prepare its petri dishes. more

9 Jun 2015 09:00 Technology

Medtech company ANGLE has apopointed James Reuben, PhD, MBA, as a Scientific Advisor to the company with immediate effect. more

3 Jun 2015 10:41 News

Advanced melanoma patients have been given new hope as an international trial has shown that a combination of the drugs iplimumab and nivolumab could shrink tumours in around 60% of cases. more

1 Jun 2015 09:26 News

Cancer researchers and immunologists at Sweden’s Karolinska Institutet have now discovered how cancer cells can infiltrate the lymphatic system by ‘disguising’ themselves as immune cells. more

14 May 2015 09:47 News

Mundipharma’s network of independent associated companies has been extended to form a new company called Mundipharma EDO (Early Development in Oncology) with the purpose of building a robust and sustainable pipeline in oncology. more

2 Jul 2014 11:19

New addition: Mundipharma’s network of independent associated companies has been extended to form a new company called Mundipharma EDO. more

23 Jun 2014 18:43 Home

Joint forces: Collaboration to utilise Cellectis' proprietary allogeneic CAR-T platform technology to develop immunotherapies against select targets in the field of oncology more

20 Jun 2014 11:09 News

Supplier in chemical development and manufacturing Lonza has established an agreement with Pharmacyclics, Inc. to support the commercial and clinical production of its oral oncology drug IMBRUVICA (Ibrutinib). This agreement follows a successful... more

13 Jan 2014 15:23 Technology

Penn Pharma’s COO provides behind-the-scenes tour of high potency facility

On 26 September, CMO Penn Pharma celebrated the official opening of its £14 million high containment facility for oral solid dosage products in Tredegar, Wales, UK. I spoke to Penn Pharma’s COO Mark Dean-Netscher about the facility’s success... more

26 Nov 2013 12:25 Editor's Blog